Measured Wealth Private Client Group LLC Acquires Shares of 9,523 CVS Health Corporation $CVS

Measured Wealth Private Client Group LLC acquired a new position in shares of CVS Health Corporation (NYSE:CVS) during the 3rd quarter, according to its most recent 13F filing with the SEC. The fund acquired 9,523 shares of the pharmacy operator’s stock, valued at approximately $718,000.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. Harbor Capital Advisors Inc. increased its stake in shares of CVS Health by 72.1% in the third quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock worth $26,000 after buying an additional 142 shares during the last quarter. Corundum Trust Company INC bought a new position in CVS Health during the 3rd quarter valued at $29,000. Front Row Advisors LLC grew its holdings in CVS Health by 436.5% during the 2nd quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock worth $31,000 after acquiring an additional 371 shares in the last quarter. Twin Peaks Wealth Advisors LLC bought a new stake in shares of CVS Health in the 2nd quarter worth about $36,000. Finally, SOA Wealth Advisors LLC. raised its stake in shares of CVS Health by 36.9% in the 3rd quarter. SOA Wealth Advisors LLC. now owns 486 shares of the pharmacy operator’s stock valued at $37,000 after purchasing an additional 131 shares in the last quarter. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

CVS has been the subject of a number of research reports. Piper Sandler reiterated an “overweight” rating and issued a $101.00 price target (up from $99.00) on shares of CVS Health in a research note on Wednesday, December 10th. Argus cut their price objective on CVS Health from $91.00 to $90.00 and set a “buy” rating on the stock in a research note on Wednesday, January 28th. Mizuho lifted their target price on CVS Health from $88.00 to $95.00 and gave the stock an “outperform” rating in a research report on Wednesday, December 10th. TD Cowen reiterated a “buy” rating on shares of CVS Health in a report on Friday. Finally, UBS Group reissued an “outperform” rating on shares of CVS Health in a research report on Wednesday, December 10th. Twenty investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, CVS Health currently has a consensus rating of “Moderate Buy” and a consensus price target of $95.05.

CVS Health Stock Down 0.4%

NYSE:CVS opened at $75.81 on Tuesday. The company has a current ratio of 0.84, a quick ratio of 0.63 and a debt-to-equity ratio of 0.80. The stock has a 50 day moving average of $78.08 and a 200-day moving average of $77.85. The firm has a market capitalization of $96.45 billion, a PE ratio of 54.94, a price-to-earnings-growth ratio of 0.79 and a beta of 0.49. CVS Health Corporation has a 52 week low of $58.35 and a 52 week high of $85.15.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.00 by $0.09. The business had revenue of $105.69 billion for the quarter, compared to the consensus estimate of $103.67 billion. CVS Health had a return on equity of 11.31% and a net margin of 0.44%.The business’s revenue was up 8.2% on a year-over-year basis. During the same quarter last year, the business posted $1.19 EPS. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. Analysts predict that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, February 2nd. Stockholders of record on Thursday, January 22nd were issued a dividend of $0.665 per share. The ex-dividend date of this dividend was Thursday, January 22nd. This represents a $2.66 annualized dividend and a dividend yield of 3.5%. CVS Health’s payout ratio is 192.75%.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.